Literature DB >> 26493646

Functional and genetic deconstruction of the cellular origin in liver cancer.

Jens U Marquardt1, Jesper B Andersen2, Snorri S Thorgeirsson3.   

Abstract

During the past decade, research on primary liver cancers has particularly highlighted the uncommon plasticity of differentiated parenchymal liver cells (that is, hepatocytes and cholangiocytes (also known as biliary epithelial cells)), the role of liver progenitor cells in malignant transformation, the importance of the tumour microenvironment and the molecular complexity of liver tumours. Whereas other reviews have focused on the landscape of genetic alterations that promote development and progression of primary liver cancers and the role of the tumour microenvironment, the crucial importance of the cellular origin of liver cancer has been much less explored. Therefore, in this Review, we emphasize the importance and complexity of the cellular origin in tumour initiation and progression, and attempt to integrate this aspect with recent discoveries in tumour genomics and the contribution of the disrupted hepatic microenvironment to liver carcinogenesis.

Entities:  

Mesh:

Year:  2015        PMID: 26493646     DOI: 10.1038/nrc4017

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  142 in total

1.  Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.

Authors:  Dung T Le; Andrea Wang-Gillam; Vincent Picozzi; Tim F Greten; Todd Crocenzi; Gregory Springett; Michael Morse; Herbert Zeh; Deirdre Cohen; Robert L Fine; Beth Onners; Jennifer N Uram; Daniel A Laheru; Eric R Lutz; Sara Solt; Aimee Luck Murphy; Justin Skoble; Ed Lemmens; John Grous; Thomas Dubensky; Dirk G Brockstedt; Elizabeth M Jaffee
Journal:  J Clin Oncol       Date:  2015-01-12       Impact factor: 44.544

2.  Primary liver carcinoma arising in people younger than 30 years.

Authors:  Walter M Klein; Ernesto P Molmenti; Paul M Colombani; Davinder S Grover; Kathleen B Schwarz; John Boitnott; Michael S Torbenson
Journal:  Am J Clin Pathol       Date:  2005-10       Impact factor: 2.493

3.  Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

Authors:  Daniela Sia; Yujin Hoshida; Augusto Villanueva; Sasan Roayaie; Joana Ferrer; Barbara Tabak; Judit Peix; Manel Sole; Victoria Tovar; Clara Alsinet; Helena Cornella; Brandy Klotzle; Jian-Bing Fan; Christian Cotsoglou; Swan N Thung; Josep Fuster; Samuel Waxman; Juan Carlos Garcia-Valdecasas; Jordi Bruix; Myron E Schwartz; Rameen Beroukhim; Vincenzo Mazzaferro; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-04       Impact factor: 22.682

Review 4.  Interleukin-6 signaling pathway in targeted therapy for cancer.

Authors:  Yuqi Guo; Feng Xu; TianJian Lu; Zhenfeng Duan; Zhan Zhang
Journal:  Cancer Treat Rev       Date:  2012-05-29       Impact factor: 12.111

5.  Whole-exome sequencing identifies mutated PCK2 and HUWE1 associated with carcinoma cell proliferation in a hepatocellular carcinoma patient.

Authors:  Yan-Xuan Liu; Shu-Fang Zhang; Ying-Hua Ji; Sheng-Ju Guo; Geng-Fu Wang; Guang-Wen Zhang
Journal:  Oncol Lett       Date:  2012-07-26       Impact factor: 2.967

Review 6.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

Authors:  Madhuri Kakarala; Max S Wicha
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

Review 7.  Classification, diagnosis, and management of cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-13       Impact factor: 11.382

Review 8.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

9.  Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.

Authors:  Yuichi Shiraishi; Akihiro Fujimoto; Mayuko Furuta; Hiroko Tanaka; Ken-ichi Chiba; Keith A Boroevich; Tetsuo Abe; Yoshiiku Kawakami; Masaki Ueno; Kunihito Gotoh; Shun-ichi Ariizumi; Tetsuo Shibuya; Kaoru Nakano; Aya Sasaki; Kazuhiro Maejima; Rina Kitada; Shinya Hayami; Yoshinobu Shigekawa; Shigeru Marubashi; Terumasa Yamada; Michiaki Kubo; Osamu Ishikawa; Hiroshi Aikata; Koji Arihiro; Hideki Ohdan; Masakazu Yamamoto; Hiroki Yamaue; Kazuaki Chayama; Tatsuhiko Tsunoda; Satoru Miyano; Hidewaki Nakagawa
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

10.  Cell-type specific functions of epidermal growth factor receptor are involved in development of hepatocellular carcinoma.

Authors:  Nikolai A Timchenko
Journal:  Hepatology       Date:  2015-05-20       Impact factor: 17.425

View more
  106 in total

1.  Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.

Authors:  Ruidong Xue; Lu Chen; Chong Zhang; Masashi Fujita; Ruoyan Li; Shu-Mei Yan; Choon Kiat Ong; Xiwen Liao; Qiang Gao; Shota Sasagawa; Yanmeng Li; Jincheng Wang; Hua Guo; Qi-Tao Huang; Qian Zhong; Jing Tan; Lisha Qi; Wenchen Gong; Zhixian Hong; Meng Li; Jingmin Zhao; Tao Peng; Yinying Lu; Kiat Hon Tony Lim; Arnoud Boot; Atushi Ono; Kazuaki Chayama; Zemin Zhang; Steve George Rozen; Bin Tean Teh; Xin Wei Wang; Hidewaki Nakagawa; Mu-Sheng Zeng; Fan Bai; Ning Zhang
Journal:  Cancer Cell       Date:  2019-05-23       Impact factor: 31.743

2.  Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.

Authors:  Coralie Allain; Gaëlle Angenard; Bruno Clément; Cédric Coulouarn
Journal:  Cancer Res       Date:  2016-09-12       Impact factor: 12.701

3.  Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells.

Authors:  Kostiantyn Dreval; Volodymyr Tryndyak; Iryna Kindrat; Nathan C Twaddle; Orish Ebere Orisakwe; Thilak K Mudalige; Frederick A Beland; Daniel R Doerge; Igor P Pogribny
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

4.  An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.

Authors:  Ying Fu; Shana Silverstein; Justine N McCutcheon; Marcin Dyba; Raghu G Nath; Monika Aggarwal; Heidi Coia; Angela Bai; Jishen Pan; Jiji Jiang; Bhaskar Kallakury; Hongkun Wang; Yu-Wen Zhang; Giuseppe Giaccone; Aiwu Ruth He; Fung-Lung Chung
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

Review 5.  Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis.

Authors:  Jens U Marquardt; Marc Nguyen-Tat; Peter R Galle; Marcus A Wörns
Journal:  Visc Med       Date:  2016-04-08

6.  Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.

Authors:  Chirag Nepal; Colm J O'Rourke; Douglas V N P Oliveira; Andrzej Taranta; Steven Shema; Prson Gautam; Julien Calderaro; Andrew Barbour; Chiara Raggi; Krister Wennerberg; Xin W Wang; Anja Lautem; Lewis R Roberts; Jesper B Andersen
Journal:  Hepatology       Date:  2018-06-12       Impact factor: 17.425

7.  Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.

Authors:  Kun-Yu Teng; Jianfeng Han; Xiaoli Zhang; Shu-Hao Hsu; Shun He; Nissar A Wani; Juan M Barajas; Linda A Snyder; Wendy L Frankel; Michael A Caligiuri; Samson T Jacob; Jianhua Yu; Kalpana Ghoshal
Journal:  Mol Cancer Ther       Date:  2016-12-15       Impact factor: 6.261

8.  Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic Genes.

Authors:  Suet-Yan Kwan; Ankur Sheel; Chun-Qing Song; Xiao-Ou Zhang; Tingting Jiang; Hien Dang; Yueying Cao; Deniz M Ozata; Haiwei Mou; Hao Yin; Zhiping Weng; Xin Wei Wang; Wen Xue
Journal:  Hepatology       Date:  2019-08-11       Impact factor: 17.425

9.  Single cell profiling reveals window for immunotherapy in liver cancers.

Authors:  Jesper B Andersen
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

10.  Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice.

Authors:  Soona Shin; Kirk J Wangensteen; Monica Teta-Bissett; Yue J Wang; Elham Mosleh-Shirazi; Elizabeth L Buza; Linda E Greenbaum; Klaus H Kaestner
Journal:  Hepatology       Date:  2016-05-28       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.